Company Short-Term Debts: Orgenesis (ORGS)

Public company logo of Orgenesis Corporation (ORGS)

Despite regulatory complexities and low transparency resulting from its network of partnerships, Orgenesis Inc. (ORGS) management aims to make gene therapy more accessible through the automation of hospital-based production. This market valuation chart for the company on GURU.Markets captures the 0.00 metric. The business relies on the biotech sector's growing demand for mobile cell processing systems, ensuring steady development within the decentralized manufacturing niche.

Orgenesis (ORGS) Company Short-Term Indebtedness: for the period 07/04/2022 - 10/26/2024

Summary analytical data breakdowns for Orgenesis Corporation (ORGS)

- price and consensus price forecast:
Price Chart Orgenesis|ORGS - Consensus Target
- market capitalization data:
Market Capitalization Orgenesis Inc.|ORGS - Total Enterprise Value
- book capitalization data:
Book Value per Share Orgenesis|ORGS - Accounting Capitalization|Market Value to Book Value Ratio orgenesis.com|ORGS - Company Assets
- debt and liquidity data:
Debt to Equity Orgenesis Inc.|ORGS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Orgenesis Inc.|ORGS - Company Total Indebtedness|Debts to Book Capitalization Orgenesis Inc.|ORGS - Long-Term Debt|Company Short-Term Debt Orgenesis
Analysis of all company metrics:Orgenesis, ORGS
Signature product of Orgenesis Corporation

Fundamental asset selection requires liquidity analysis by monitoring obligations maturing within one year. This indicator measures current debt load and interest rate sensitivity, which is critical for Orgenesis Inc. (ORGS) amid the loss of market share in cell therapy; therefore, the total amount of short-term debt on this chart serves as a marker of the company's solvency in a highly competitive environment.

Competitor analysis for Orgenesis Inc.

VEEV: Company Short-Term Debt|DOCS - Company Current Liabilities|Company Short-Term Debts HQY|Waystar Corp (WAY) - Short-Term Debt|Company Short-Term Debts CorVel Corporation (CRVL)|Company Short-Term Indebtedness PRVA|Huron - Company Short-Term Debt|Short-Term Debt CERT (Certara Inc)|Company Short-Term Debt Omnicell Corp|Company Short-Term Loans and Borrowings GoodRx Gold GDRX|Company Short-Term Debts SDGR|PHR - Short-Term Indebtedness|Company Short-Term Debts OMDA|EVH (Evolent Health Inc) - Short-Term Debt|Company Short-Term Debt HealthStream Corp (HSTM)|Company Short-Term Indebtedness Definitive Corp|Consensus Cloud Solutions - Company Short-Term Debts|Short-Term Debt AGL (agilonhealth.com)|Company Short-Term Debt ABSI|Short-Term Debt Volume So-Young International Inc SY|Company Short-Term Debts NRC (National Research Corp.)|SPOK: Short-Term Debt Volume|OptimizeRx Corporation - Company Short-Term Debt|Short-Term Debt Volume trubridge.com|SLP - Company Current Liabilities|Company Short-Term Loans and Borrowings SOPHiA GENETICS S.A.|HCAT (Health Catalyst, Inc) - Company Short-Term Debts|Short-Term Debt Volume CCLD (carecloud.com)|RSSS - Company Short-Term Debt|Company Short-Term Indebtedness DLH Corp DLHC|ONMD: Company Short-Term Debts|Scienture Holdings (SCNX) - Company Current Liabilities|Healthcare Triangle Corp - Company Current Liabilities|ISPC (iSpecimen) - Short-Term Debt Volume|Company Short-Term Debt BFRG (Bullfrog AI Holdings, Inc.)|Short-Term Debt WORX|MSP Recovery (MSPR) - Company Short-Term Debt|Company Short-Term Loans and Borrowings icoreconnect.com (ICCT)|MEDS (TRxADE) - Company Short-Term Debts|R1 RCM, Inc. - Short-Term Indebtedness|Company Short-Term Debt SHCR (Sharecare, Inc.)|STRM - Short-Term Debt Volume|Syra Health - Company Short-Term Debts|Short-Term Debt Volume Apollo Medical Holdings, Inc.|Model N Corp (MODN) - Company Current Liabilities|Amount of Current Liabilities NextGen Healthcare Corp (NXGN)